CorEVITAS Abs 1499 #ACRbest #ACR22 cycling to a second line TNFi provides limited benefits to pts with AxSpA who discontinued a first line TNFi. @RheumNow
https://t.co/fKDa5kPfXN https://t.co/CtMCj2Ihgc
Links:
The Impact of Cycling Among Tumor Necrosis Factor Inhibitors on Disease Control…
http://ow.ly/vp7150LyZMv
13-11-2022